// App-Quantinova.ai

439 : Clinical Characteristics of Patients with ANCA-Associated Vasculitis with and Without Alpha-1 Antitrypsin Deficiency Alleles

Researchers

Presenter

  • Lynn Fussner

Principal Investigators

  • David Cuthbertson

  • Peter Grayson

  • David Jayne

  • Carol McAlear

  • Michael Walsh

  • Katherine Siminovitch

  • Ulrich Specks

  • Peter Merkel

Medical Centers

  • The Ohio State Univerisity, Columbus, OH

  • University of South Florida, Tampa, FL

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD

  • University of Cambridge, Cambridge, United Kingdom

  • Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, USA, Philadelphia, PA

  • McMaster University, Hamilton, ON, Canada

  • University of Toronto, Toronto, ON, Canada

  • Mayo Clinic, Rochester, MN

  • University of Pennsylvania, Philadelphia, PA

Locations

  • United States

  • United Kingdom

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Genetic Disorder

Disease

  • Wegener's granulomatosis

  • Alpha-1 antitrypsin (A1AT) deficiency

  • Anti-neutrophil cytoplasmic antibody-associated vasculitis

  • Microscopic polyangiitis

Biomarkers

  • Alpha-1 antitrypsin

Drug/Treatment

  • Alpha 1-Antitrypsin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved